Literature DB >> 7629018

Protein factors required for in vitro transcription of Sendai virus genome.

K Mizumoto1, K Muroya, T Takagi, T Omata-Yamada, H Shibuta, K Iwasaki.   

Abstract

To elucidate the mechanism of transcription and replication of Sendai virus, we developed an efficient and faithful in vitro transcription system using purified virus particles. The in vitro RNA synthesis was almost entirely dependent on the addition of eukaryotic cell extracts, including those from various cultured mammalian cells, mammalian tissues, and even from plant cells. The RNA products were almost identical to authentic mRNA species synthesized in the infected cells, in their size distribution, the presence of 3'-poly(A) tail and the presence of methylated 5'-cap structure (m7GpppAm). Ribonuclease protection experiments after annealing the in vitro RNA with viral genomic RNA (vRNA) indicated that the virion-associated RNA-dependent RNA polymerase transcribes correct regions of the RNA genome in vitro. The active component(s) that is required for Sendai virus mRNA synthesis was partially purified from bovine brain and was separated into at least two complementary fractions, one of which could be replaced by highly purified cellular tubulin. When viral ribonucleoprotein complexes were used instead of virus particles in the in vitro transcription, only Sendai virus-infected cell extracts supported mRNA synthesis, and extracts from uninfected cells or cells infected with other viruses were found to be inert. These results suggest that, in addition to the general factors which are present ubiquitously in eukaryotic cells, a factor(s) specific to Sendai virus-infection is required for Sendai virus transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629018     DOI: 10.1093/oxfordjournals.jbchem.a124740

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

Review 1.  In vitro capping and transcription of rhabdoviruses.

Authors:  Tomoaki Ogino
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

2.  Positive and negative host factors for Sendai virus transcription and their organ distribution in rat.

Authors:  T Takagi; M Iwama; K Seta; T Kanda; T Tsukamoto; S Tominaga; K Mizumoto
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Association of ebola virus matrix protein VP40 with microtubules.

Authors:  Gordon Ruthel; Gretchen L Demmin; George Kallstrom; Melodi P Javid; Shirin S Badie; Amy B Will; Timothy Nelle; Rowena Schokman; Tam L Nguyen; John H Carra; Sina Bavari; M Javad Aman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.

Authors:  Andrea M Murphy; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

5.  Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins.

Authors:  M Takeda; A Kato; F Kobune; H Sakata; Y Li; T Shioda; Y Sakai; M Asakawa; Y Nagai
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 6.  RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Authors:  Juan A Bernal
Journal:  J Cardiovasc Transl Res       Date:  2013-07-13       Impact factor: 4.132

Review 7.  Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.

Authors:  Mahito Nakanishi; Makoto Otsu
Journal:  Curr Gene Ther       Date:  2012-10       Impact factor: 4.391

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.